Rus Eng
Main / Company's news / "GEROPHARM" represented on expert panel for congress named "Innovative technologies in endocrinology"

"GEROPHARM" represented on expert panel for congress named "Innovative technologies in endocrinology"

30 May 2014

From 25 to 28 May, Moscow hosted the second All-Russia congress named “Innovative technologies in endocrinology”, in which a number of CIS countries were represented. Chairing the Scientific and Organisational Committee was Veronika Skvortsova, Minister of Health of the Russian Federation and Academician Ivan Dedov, President of the non-governmental organisation named “The Russian Association of Endocrinologists”, and Director of the federal state budgetary enterprise named “Endocrinology Research Centre” attached to the Ministry of Health.

The All-Russia Congress “Innovative technologies in endocrinology” is a prestigious medical forum held at the international level. This year, it brought together over 1300 specialists in the field of endocrinology and related professions from the Russian Federation, the CIS, Europe, and the USA.

On the agenda of the Congress were symposiums, plenary lectures, seminars, round tables, demonstrations of the latest information technologies and research paper contests for young scientists, each of which was a place for discussion of current issues in the key areas of endocrinology. The main topics for discussion were as follows: Epidemiology of endocrine diseases. The future of endocrinology – preventive, predictive, personalized medicine in the XXI century. Genome analysis – a new paradigm for solving medico-genetic problems. Technologies for integrating achievements of molecular medicine into clinical practice. Modern strategy of diagnostics, treatment, and preventive care of diabetes and its complications. Innovative achievements in diagnostics, treatment, and preventive care of neuroendocrine diseases. Reproductive medicine: high technologies in gynaecology and andrology. Current issues in endocrine surgery. Improving the system of higher professional (medical) education, information technologies for continuing professional education in endocrinology, and many more.

According to long-standing tradition, the Congress was accompanied by an exhibition that ran parallel to it and had in attendance some of the leading manufacturers of pharmaceuticals and medical products companies, both Russian and foreign.

GEROPHARM, being one of the experts in fully-localised, full-cycle production of genetically engineered human insulin, also had its display there. An innovative highlight of the display was the robot that would tell the visitors of the Congress about the company and its achievements. GEROPHARM, Group of Companies is engaged in the development and production of Russia-made innovative medicines for treatment of socially significant diseases treatment as well as of generics that are prioritised in terms of import substitution opportunities.

In 2013, the town of Obolensk in the Moscow region saw the opening of GEROPHARM-Bio, an industrial GMP complex. This enterprise is unparalleled both in the Moscow region and Russia-wide as it creates an environment for ensuring medicinal safety by localising, for the first time, all the phases of production of genetically engineered human insulins, which are socially significant medicines, within the territory of the country, as well as addresses the problem of import substitution, which is so crucial today.

GEROPHARM is implementing a number of projects under federal special-purpose programmes of the Ministry of Industry and Trade and the Ministry of Education and Science of the Russian Federation, including a project for creating insulin analogues.

GEROPHARM’s participation in an event of such significance to the endocrinology community is very important, because it provides an opportunity to obtain advanced scientific knowledge and practical expertise, to exchange experiences, and to make a name for the Group.

You are a health care professional?

Go up